Biblio

33557 resultats trouvés
V
Jacquin A., Virat-Brassaud M.-E, Rouaud O., Osseby G.-V, Aboa-Eboule C., Hervieu M., Menassa M., Ricolfi F., Giroud M., Bejot Y..  2014.  Vascular Aphasia Outcome after Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis for Ischemic Stroke. EUROPEAN NEUROLOGY. 71:288-295.
Bordy R, Quirie A, Marie C, Wendling D, Totoson P, Demougeot C.  2020.  Vascular Arginase Is a Relevant Target to Improve Cerebrovascular Endothelial Dysfunction in Rheumatoid Arthritis: Evidence from the Model of Adjuvant-Induced Arthritis. TRANSLATIONAL STROKE RESEARCH. 11:4-15.
Pedard M, Quirie A, Totoson P, Verhoeven F, Garnier P, Tessier A, Demougeot C'line, Marie C.  2019.  Vascular brain-derived neurotrophic factor pathway in rats with adjuvant-induced arthritis: Effect of anti-rheumatic drugs (vol 274, pg 77, 2018). ATHEROSCLEROSIS. 280:201.
Pedard M, Quirie A, Totoson P, Verhoeven F, Gamier P, Tessier A, Demougeot C, Marie C.  2018.  Vascular brain-derived neurotrophic factor pathway in rats with adjuvant-induced arthritis: Effect of anti-rheumatic drugs. ATHEROSCLEROSIS. 274:77-85.
Hannappe M-A, Arnould L, Meloux A, Mouhat B, Bichat F, Zeller M, Cottin Y, Binquet C, Vergely C, Creuzot-Garcher C et al..  2020.  Vascular density with optical coherence tomography angiography and systemic biomarkers in low and high cardiovascular risk patients. SCIENTIFIC REPORTS. 10:16718.
Krause D., Bartoli J-M.  2015.  Vascular emergencies: Diagnosis and treatment. DIAGNOSTIC AND INTERVENTIONAL IMAGING. 96:655-656.
Geindreau M, Ghiringhelli F, Bruchard M.  2021.  Vascular Endothelial Growth Factor, a Key Modulator of the Anti-Tumor Immune Response. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 22:4871.
Gabrielle P-H, Nguyen V, Creuzot-Garcher C, Miguel L, Alforja S, Sararols L, Casaroli-Marano RP, Zarranz-Ventura J, Gillies M, Arnold J et al..  2022.  Vascular endothelial growth factor inhibitors for predominantly Caucasian myopic choroidal neovascularization: 2-year treatment outcomes in clinical practice: data from the Fight Retinal Blindness! Registry. ACTA OPHTHALMOLOGICA. 100:E288-E296.
Prati C, Demougeot C, Guillot X, Sondag M, Verhoeven F, Wendling D.  2019.  Vascular involvement in axial spondyloarthropathies. JOINT BONE SPINE. 86:159-163.
Gavazov K, Albrecht R, Buttler A, Dorrepaal E, Garnett MH, Gogo S, Hagedorn F, Mills RTE, Robroek BJM, Bragazza L.  2018.  Vascular plant-mediated controls on atmospheric carbon assimilation and peat carbon decomposition under climate change. GLOBAL CHANGE BIOLOGY. 24:3911-3921.
Kleinclauss F., Frontczak A., Balssa L., Lebdai S., Azzouzi R..  2019.  Vascular targeted photodynamic therapy in low-risk prostate cancer. A literature review. PROGRES EN UROLOGIE. 29:393-401.
Abou-Arab O, Kamel S, Beyls C, Huette P, Bar S, Lorne E, Galmiche A, Guinot P-G.  2020.  Vasoplegia After Cardiac Surgery Is Associated With Endothelial Glycocalyx Alterations. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA. 34:900-905.
Dargent A, Nguyen M, Fournel I, Bourredjem A, Charles P-E, Quenot J-P, Grp EPISSStudy.  2018.  VASOPRESSOR CUMULATIVE DOSE REQUIREMENT AND RISK OF EARLY DEATH DURING SEPTIC SHOCK: AN ANALYSIS FROM THE EPISS COHORT. SHOCK. 49:625-630.
Dargent A, Quintin L, Jacquier M, Fournel I, Quenot J-P.  2020.  Vasopressor for refractory septic shock: dexmedetomidine could help decrease norepinephrine requirements. MINERVA ANESTESIOLOGICA. 86:885-886.
Guinot P-G, Martin A, Berthoud V, Voizeux P, Bartamian L, Santangelo E, Bouhemad B, Nguyen M.  2021.  Vasopressor-Sparing Strategies in Patients with Shock: A Scoping-Review and an Evidence-Based Strategy Proposition. JOURNAL OF CLINICAL MEDICINE. 10:3164.
Wisutthathum S, Chootip K, Martin H, Ingkaninan K, Temkitthawon P, Totoson P, Demougeot C.  2018.  Vasorelaxant and Hypotensive Effects of an Ethanolic Extract of Eulophia macrobulbon and Its Main Compound 1-(4'-Hydroxybenzyl)-4,8-Dimethoxyphenanthrene-2,7-Diol. FRONTIERS IN PHARMACOLOGY. 9:484.
Arraki K., Maroilley J., Demougeot C., Girard C., Totoson P..  2019.  Vasorelaxant effect of Cyperus thunbergii on thoracic aorta rings from rats. FUNDAMENTAL & CLINICAL PHARMACOLOGY. 33:29.
Arraki K., Maroilley J., Demougeot C., Girard C., Totoson P..  2019.  Vasorelaxant effect of Cyperus thunbergii on thoracic aorta rings from rats. FUNDAMENTAL & CLINICAL PHARMACOLOGY. 33:29.
Bujor A, Miron A, Luca SVlad, Skalicka-Wozniak K, Silion M, Trifan A, Girard C, Demougeot C, Totoson P.  2020.  Vasorelaxant effects of Crataegus pentagyna: Links with arginase inhibition and phenolic profile. JOURNAL OF ETHNOPHARMACOLOGY. 252:112559.
Bujor A, Miron A, Luca SVlad, Skalicka-Wozniak K, Silion M, Trifan A, Girard C, Demougeot C, Totoson P.  2021.  Vasorelaxant effects of Crataegus pentagyna: Links with arginase inhibition and phenolic profile (vol 252, 112559, 2020). JOURNAL OF ETHNOPHARMACOLOGY. 273:113962.
Wisutthathum S., Totoson P., Chootip K., Ingkaninan K., Martin H., Demougeot C..  2018.  Vasorelaxant effects of Eulophia macrobulbon and its main compound in rat mesenteric arteries. FUNDAMENTAL & CLINICAL PHARMACOLOGY. 32:58.
Wisutthathum S., Totoson P., Chootip K., Ingkaninan K., Martin H., Demougeot C..  2018.  Vasorelaxant effects of Eulophia macrobulbon and its main compound in rat mesenteric arteries. FUNDAMENTAL & CLINICAL PHARMACOLOGY. 32:58.
Totoson P., Marie C., Demougeot C..  2017.  Vasorelaxing effect of a TrkB receptor agonist on mesenteric arteries. FUNDAMENTAL & CLINICAL PHARMACOLOGY. 31:21.
Totoson P., Marie C., Demougeot C..  2017.  Vasorelaxing effect of a TrkB receptor agonist on mesenteric arteries. FUNDAMENTAL & CLINICAL PHARMACOLOGY. 31:21.
Rabani V., Montange D., Davani S..  2016.  VASP interactive network analysis in lipid raft of platelets. FUNDAMENTAL & CLINICAL PHARMACOLOGY. 30:75.

Pages